您好,欢迎来到试剂仪器网! [登录] [免费注册]
试剂仪器网
位置:首页 > 产品库 > iHCK-37
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
iHCK-37
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
iHCK-37图片
规格:98%
分子量:544.73
包装与价格:
包装价格(元)
5mg电议
10mg电议
25mg电议

产品介绍
iHCK-37 (ASN05260065) 是一种有效的特异性 Hck 抑制剂,Ki 值为 0.22 μM。iHCK-37 阻断 HIV-1 病毒复制,其 EC50 值为 12.9 μM。iHCK-37 可用于慢性髓系白血病(CML)研究。
货号:ajcx36008
CAS:516478-09-4
分子式:C30H32N4O2S2
分子量:544.73
溶解度:DMSO : 275 mg/mL (504.84 mM; Need ultrasonic)
纯度:98%
存储:Store at -20°C
库存:现货

Background:

iHCK-37 (ASN05260065) is a potent and specific Hck inhibitor with a Ki value of 0.22 μM. iHCK-37 blocks HIV-1 viral replication with an EC50 value of 12.9 μM. iHCK-37 is used for chronic myeloid leukemia (CML) research[1].

iHCK-37 (5.0-20 μM; 24 hours) exhibits a potent in vitro antiproliferative activity. The dose (μM) for growth inhibition (GI50) is 5.0-5.8 μM for AML cell lines (HL60, KG1a and U937) and 9.1-19.2 μM for chronic myeloid leukemia cell lines (HEL and K562)[2].iHCK-37 (3-9 μM; plus Erythropoietin) leads to a decrease in ERK, AKT and P70S6K phosphorylation of in lentivirus HCK silenced K562 and U937 cell lines[2].iHCK-37 (3-9 μM) results in a decrease of p-HCK, p-ERK, p-AKT, p-70S6 in the cell line KG1a (AML/CD34+), in a dose-dependent manner[2].

[1]. Cristina Tintori, et al. Identification of Hck inhibitors as hits for the development of antileukemia and anti-HIV agents. ChemMedChem. 2013 Aug;8(8):1353-60.
[2]. Fernanda Marconi Roversi, et al. Hematopoietic cell kinase (HCK) is a potential therapeutic target for dysplastic and leukemic cells due to integration of erythropoietin/PI3K pathway and regulation of erythropoiesis: HCK in erythropoietin/PI3K pathway. Biochim Biophys Acta Mol Basis Dis. 2017 Feb;1863(2):450-461.